You can buy or sell Eisai and other stocks, options, ETFs, and crypto commission-free!
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. Read More The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan. ESALY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
52 Week High
52 Week Low
Eisai Receives the President's Award of the Japan Techno-Economics Society at the 8th Technology Management and Innovation AwardsMedia Inquiries: Public Relations Department, Eisai Co., Ltd. +81-(0)3-3817-5120 TOKYO, Feb 21, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it